Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients-Reference-Cited by-同舟云学术

Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients

Published:2015-02-03 Issue:4 Volume:37 Page:601-606
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Chen Qing-Jie,Li Jing,Zuo Shan-Ru,Zhang Ya-Ping,Jia Su-Jie,Yuan Hong,Liu Shi-Kun,Cheng Ke,Ming Ying-Zi,Zuo Xiao-Cong,Luo Ai-Jing,Xie Wen-Zhao,Cai Jing-Jing,Yang Meng,Wang Jiang-Lin

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2015.1007833

Reference22 articles.

1. Guidelines for the treatment and management of new-onset diabetes after transplantation1.

2. Diabetes mellitus in transplantation: 2002 consensus guidelines

3. Diabetes Mellitus after Kidney Transplantation in the United States

4. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative glucose monitoring with continuous glucose monitors identifies risk factors for post-transplant diabetes mellitus in kidney transplant recipients;Scientific Reports;2024-09-11

2. Immunosuppressive Therapy and Nutritional Diseases of Patients after Kidney Transplantation: A Systematic Review;2024-08-23

3. Syk/BLNK/NF-κB signaling promotes pancreatic injury induced by tacrolimus and potential protective effect from rapamycin;Biomedicine & Pharmacotherapy;2024-02

4. Association between Genetic Polymorphisms and Risk of Kidney Posttransplant Diabetes Mellitus: A Systematic Review and Meta-Analysis;International Journal of Clinical Practice;2022-03-08

5. The Expression Pattern and Regulatory Mechanism of the G0/G1 Switch Gene 2 (G0S2) in the Pathogenesis and Treatment of AChR Myasthenia Gravis (MG);Mediators of Inflammation;2020-09-29